Kilicarslan, A. Et Al. 2008. Fenofibrate improves endothelial function and decreases thrombin-activatable fibrinolysis inhibitor concentration in metabolic syndrome. BLOOD COAGULATION & FIBRINOLYSIS , vol.19, no.4 , 310-314.

Kilicarslan, A., Yavuz, B., Guven, G. S., ATALAR, E., Sahiner, L., BEYAZIT, Y., ... KEKİLLİ, M.(2008). Fenofibrate improves endothelial function and decreases thrombin-activatable fibrinolysis inhibitor concentration in metabolic syndrome. BLOOD COAGULATION & FIBRINOLYSIS , vol.19, no.4, 310-314.

Kilicarslan, Alpaslan Et Al. "Fenofibrate improves endothelial function and decreases thrombin-activatable fibrinolysis inhibitor concentration in metabolic syndrome," BLOOD COAGULATION & FIBRINOLYSIS , vol.19, no.4, 310-314, 2008

Kilicarslan, Alpaslan Et Al. "Fenofibrate improves endothelial function and decreases thrombin-activatable fibrinolysis inhibitor concentration in metabolic syndrome." BLOOD COAGULATION & FIBRINOLYSIS , vol.19, no.4, pp.310-314, 2008

Kilicarslan, A. Et Al. (2008) . "Fenofibrate improves endothelial function and decreases thrombin-activatable fibrinolysis inhibitor concentration in metabolic syndrome." BLOOD COAGULATION & FIBRINOLYSIS , vol.19, no.4, pp.310-314.

@article{article, author={Alpaslan Kilicarslan Et Al. }, title={Fenofibrate improves endothelial function and decreases thrombin-activatable fibrinolysis inhibitor concentration in metabolic syndrome}, journal={BLOOD COAGULATION & FIBRINOLYSIS}, year=2008, pages={310-314} }